Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Multicenter Open-label Randomized Clinical Trial Comparing Everolimus and Low Dose Tacrolimus to Tacrolimus and Mycophenolate Mofetil at 6 mo Post-Transplant to Prevent Long-term Complications After Pediatric Heart Transplantation

NCT03386539 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT03386539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03386539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Multicenter Open-label Randomized Clinical Trial Comparing Everolimus and Low Dose Tacrolimus to Tacrolimus and Mycophenolate Mofetil at 6 mo Post-Transplant to Prevent Long-term Complications After Pediatric Heart Transplantation
Lead sponsor
Boston Children's Hospital
Phase
Phase 3
Overall status
Completed
Start date
January 29, 2018
Completion date
May 17, 2023
Enrollment
211 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac allograft vasculopathy, chronic kidney diseases, heart transplant failure and rejection, heart transplant infection, immunosuppression, pediatric heart transplantation, post-transplant lymphoproliferative disorder